BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Position in NVCR — NovoCure Ltd

CIK 1520354 Paris, I0

Position in NVCR

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,974,874

-$1,580,222 QoQ

Shares Held

262,368

-48.5% QoQ

Ownership

0.225%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#49

of 217 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $1,338,823,851 across 40 Medical Devices names. NVCR ranks #17 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	5,380,866	$229,655,358
2	DXCM	Dexcom Inc	2,729,905	$183,859,100
3	EW	Edwards Lifesciences Corp	1,942,132	$175,685,257
4	MDT	Medtronic plc	1,980,901	$154,965,883
5	SYK	Stryker Corp	457,881	$144,159,252
6	IRTC	iRhythm Holdings, Inc.	866,528	$103,073,505
7	GMED	Globus Medical Inc	1,027,808	$81,207,108
8	PRCT	PROCEPT BioRobotics Corp	2,823,849	$63,762,509

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,974,874	262,368	-48.5%	Shares	Defined	2026-08-13
2026-03-31	$5,555,096	509,642	+36.5%	Shares	Defined	2026-05-14
2025-12-31	$4,827,957	373,392	+32284.4%	Shares	Defined	2026-02-13
2025-09-30	$14,896	1,153	+9.8%	Shares	Defined	2025-11-07
2025-06-30	$18,690	1,050	-90.5%	Shares	Defined	2025-08-06
2023-06-30	$460,235	11,090	-89.7%	Shares	Defined	2023-08-08
2023-03-31	$6,458,795	107,396	-2.9%	Shares	Defined	2023-05-08
2022-12-31	$8,115,590	110,642	-3.8%	Shares	Defined	2023-02-10
2022-09-30	$8,739,827	115,028	-1.3%	Shares	Defined	2022-11-10
2022-06-30	$8,101,198	116,564	+4220.4%	Shares	Defined	2022-08-04
2022-03-31	$223,529	2,698	—	Shares	Defined	2022-05-12
No filing history on record for this holder in this stock.